Press Releases

National Brain Tumor Society Applauds Medicare’s Coverage Decision for Tumor Treatment Field Therapy On the heels of the first-ever Glioblastoma Awareness Day (#GBMDay) in the United States, we’ve received some terrific news for patients that is a direct result of the brain tumor community’s advocacy efforts. As you know, there are only four drugs and one device currently approved by the U.S. Food and Drug Administration (FDA) for […] July 18, 2019

A Message of Thanks to Our Friends at Accelerate Brain Cancer Cure For more than 18 years, our friends at Accelerate Brain Cancer Cure (ABC2) have been a fixture in the brain tumor community. Their leadership, collaborative spirit, and entrepreneurial approach to research funding has helped advance the field of neuro-oncology, and the legacy of this work will continue to benefit patients and families as we work […] July 11, 2019

National Brain Tumor Society Welcomes Opening of First Clinical Site and Enrollment for GBM AGILE Adaptive Trial The Global Coalition for Adaptive Research (GCAR), the organization sponsoring the GBM AGILE clinical trial platform, announced today that it is officially opening its first trial site, the Henry Ford Cancer Institute, and will begin enrolling patients on its first treatment arm with the Bayer drug regorafenib. GBM AGILE (Adaptive Global Innovative Learning Environment) is […] June 19, 2019

Glioblastoma Awareness Day Resolution Passes U.S. Senate with Unanimous Support National Brain Tumor Society (NBTS) proudly endorsed and championed the bipartisan Senate Resolution 245, designating July 17, 2019, as “Glioblastoma Awareness Day.” Introduced on May 16 by U.S. Senator Lindsey Graham (R-SC), with the support of co-sponsors Senate Majority Leader Mitch McConnell (R-KY), Senators Elizabeth Warren (D-MA), Kyrsten Sinema (D-AZ), Martha McSally (R-AZ), and Ed […] June 12, 2019

“Annual Report to the Nation on the Status of Cancer” Finds Brain Tumor Death Rates Not Improving for Fourth Straight Year, Despite Positive Overall Trends in Cancer Results underscore need to better understand the biology of brain tumors and more rapidly advance potential treatments from the lab into innovative clinical trials Last week, the 2019 Annual Report to the Nation on the Status on Cancer — prepared yearly by the National Cancer Institute (NCI), Centers for Disease Control and Prevention (CDC), the […] June 7, 2019